In hyperglycemia, advanced glycation end-product upregulation and endothelial dysfunction induce a surge of biomolecules, such as vascular endothelial growth factor and plasminogen activator inhibitor-1 (PAI-1), which are essential in atherosclerotic plaque formation [15]. Here, SERPINE1 is linked to endothelial dysfunction.